Roivant Sciences Ltd., Director, 10% Owner at Immunovant, Inc. (IMVT), bought 6,000,000 shares at $38.00 ($228.0M) on 2023-10-02, disclosed to the SEC on 2023-10-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.00 | 1,526,316 | $58.0M | 25.4% |
| 2 | $38.00 | 4,473,684 | $170.0M | 74.6% |
| Total | $38.00 avg | 6,000,000 | $228.0M | 100% |
| Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |
| IMVT | BUY | 2020-04-17 | $30.0M | — | Filing → |